Post ASCO 2021 What Changes Monday Morning? Live Q&A Panels
Videos
Post ASCO 2021 What Changes Monday Morning? Live Q&A Panels
Post ASCO 2021 Expert Panel Discussion on Breast Cancers: Adjuvant Olaparib for High-Risk EBC, Metastatic CDK4/6i, Talazoparib for BRCA1/2-m EBC, PBC vs. Capecitabine for TNBC
FEATURING
Kevin Kalinsky,
Ann Partridge,
Terry Mamounas,
Kristina Mirabeau-Beale,
Foluso Olabisi Ademuyiwa
- 183 views
- July 7, 2021
- 2